Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
Authors
Keywords
Biomarker, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease, Anti-TNF therapy
Journal
EBioMedicine
Volume 66, Issue -, Pages 103329
Publisher
Elsevier BV
Online
2021-04-15
DOI
10.1016/j.ebiom.2021.103329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
- (2021) Fang Liu et al. Frontiers in Medicine
- Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan
- (2020) Hisashi Shiga et al. Scientific Reports
- Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies
- (2020) Lorenzo Bertani et al. Clinical and Translational Gastroenterology
- The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases
- (2020) Nikolas Dovrolis et al. Microorganisms
- Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)
- (2020) S. Vatn et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier
- (2020) Nastya Kharlamova et al. Frontiers in Immunology
- Serum Biomarkers for Inflammatory Bowel Disease
- (2020) Peng Chen et al. Frontiers in Medicine
- Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
- (2020) Jon R. Florholmen et al. BMC GASTROENTEROLOGY
- Biomarkers of inflammation in Inflammatory Bowel Disease: how long before abandoning single-marker approaches?
- (2020) Gabriele Dragoni et al. DIGESTIVE DISEASES
- Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease
- (2020) Suruchi K Batra et al. INFLAMMATORY BOWEL DISEASES
- Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota
- (2020) Clio P Mavragani et al. INFLAMMATORY BOWEL DISEASES
- Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
- (2020) Raja Atreya et al. Frontiers in Medicine
- Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
- (2019) Bram Verstockt et al. EBioMedicine
- Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease
- (2019) Ming-Hsi Wang et al. Journal of Crohns & Colitis
- P008 Proteomic markers of response to anti-TNF drugs in patients with Crohn's disease
- (2019) R Medina-Medina et al. Journal of Crohns & Colitis
- Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease
- (2019) Steffen Bank et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
- (2019) Martine A. Aardoom et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
- (2019) Lyssia Belarif et al. JOURNAL OF CLINICAL INVESTIGATION
- Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis
- (2019) Gole et al. Cells
- Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
- (2019) Konrad Aden et al. GASTROENTEROLOGY
- Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: a Systematic Review
- (2019) Maria Manuela Estevinho et al. Clinical Gastroenterology and Hepatology
- Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
- (2019) Sare Verstockt et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- DEVELOPMENT AND VALIDATION OF A TEST TO MONITOR ENDOSCOPIC ACTIVITY IN PATIENTS WITH CROHN’S DISEASE BASED ON SERUM LEVELS OF PROTEINS
- (2019) Geert D’Haens et al. GASTROENTEROLOGY
- Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
- (2019) Javier P Gisbert et al. Journal of Crohns & Colitis
- TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer
- (2019) Guanglin Cui Frontiers in Oncology
- HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
- (2019) Aleksejs Sazonovs et al. GASTROENTEROLOGY
- Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
- (2018) A. Barré et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-label Trial of Patients With Ulcerative Colitis
- (2018) Shannon E. Telesco et al. GASTROENTEROLOGY
- Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
- (2018) Renaud Gaujoux et al. GUT
- TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn’s disease patients?
- (2018) Bram Verstockt et al. GUT
- Predicting response after infliximab salvage in acute severe ulcerative colitis
- (2018) Matthew C Choy et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
- (2018) Matthew K. Doherty et al. mBio
- Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing
- (2018) Bram Verstockt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn’s Disease
- (2018) Belén Beltrán et al. DIGESTIVE DISEASES
- From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
- (2018) Maria Gloria Mumolo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci
- (2018) Kimi Drobin et al. INFLAMMATORY BOWEL DISEASES
- Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
- (2018) Yael Haberman et al. Nature Communications
- Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial
- (2017) Thomas Van Stappen et al. GUT
- Can We Predict the Efficacy of Anti-TNF-α Agents?
- (2017) Loris Lopetuso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
- (2017) Jean-Frederic Colombel et al. LANCET
- A role for oncostatin M in inflammatory bowel disease
- (2017) Walter M Kim et al. NATURE MEDICINE
- Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
- (2017) Vendel Kristensen et al. Gastroenterology Research and Practice
- Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex
- (2017) Johanne Brooks et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Review article: the practical management of acute severe ulcerative colitis
- (2016) D. Seah et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases
- (2016) S. Bek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis
- (2016) Trine Olsen et al. CYTOKINE
- Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC
- (2016) Amanda E Starr et al. GUT
- Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohnʼs Disease
- (2016) Frauke Degenhardt et al. INFLAMMATORY BOWEL DISEASES
- Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
- (2016) Maria K. Magnusson et al. Journal of Crohns & Colitis
- Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis
- (2016) Iris Detrez et al. Journal of Crohns & Colitis
- Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease
- (2016) Clare Moore et al. Journal of Crohns & Colitis
- Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis
- (2016) Fenming Zhang et al. PLoS One
- Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
- (2016) Giorgia Bodini et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
- (2016) Jerzy Ostrowski et al. Scientific Reports
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment
- (2015) Johannan F. Brandse et al. Journal of Crohns & Colitis
- Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
- (2015) X. Roblin et al. Journal of Crohns & Colitis
- Epidemiology and risk factors for IBD
- (2015) Ashwin N. Ananthakrishnan Nature Reviews Gastroenterology & Hepatology
- Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
- (2014) Y. Mazor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
- (2014) Freddy Cornillie et al. GUT
- The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
- (2014) Niels Vande Casteele et al. GUT
- Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD
- (2014) Madeline Therese Frederiksen et al. INFLAMMATORY BOWEL DISEASES
- Molecular pathways controlling barrier function in IBD
- (2014) Raja Atreya et al. Nature Reviews Gastroenterology & Hepatology
- Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
- (2014) Florian Beigel et al. PLoS One
- Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease
- (2014) Éva Pallagi-Kunstár WORLD JOURNAL OF GASTROENTEROLOGY
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
- (2013) Fernando Magro et al. Journal of Crohns & Colitis
- Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease
- (2013) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
- (2012) W. Reinisch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
- (2012) Pauliina Molander et al. INFLAMMATORY BOWEL DISEASES
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
- (2012) Martin Bortlik et al. Journal of Crohns & Colitis
- The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease
- (2012) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis
- (2012) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
- (2011) A.A. Fasanmade et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab†
- (2010) Zhe Li et al. INFLAMMATORY BOWEL DISEASES
- Infliximab therapy decreases the levels of TNF-α and IFN-γ mRNA in colonic mucosa of ulcerative colitis
- (2009) Trine Olsen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Proteomics for prediction and characterization of response to infliximab in Crohn's disease: A pilot study
- (2008) Marie-Alice Meuwis et al. CLINICAL BIOCHEMISTRY
- Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease
- (2008) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More